SCHEMBL6237385

SCHEMBL6237385

CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)CN(CC2CCCCC2)C(=O)Nc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.92

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
F10 P00742 12/20 0.92
FPR2 P25090 6/20 0.45
FPR1 P21462 4/20 0.45
SLC6A9 P48067 1/20 0.41
SLC6A5 Q9Y345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6241120 0.99 F10 (0.94) F10FPR2FPR1
SCHEMBL6241778 0.98 F10 (0.94) F10FPR2FPR1
SCHEMBL6240640 0.96 F10 (1.00) F10FPR2FPR1
SCHEMBL6278106 0.92 F10 (0.80) F10FPR2FPR1
SCHEMBL6834787 0.88 F10 (0.85) F10FPR2FPR1
SCHEMBL6839120 0.88 F10 (0.85) F10
SCHEMBL6278203 0.87 F10 (0.75) F10FPR2FPR1SLC6A9SLC6A5
SCHEMBL6323784 0.86 F10 (0.79) F10FPR2FPR1
SCHEMBL6270626 0.86 F10 (0.79) F10FPR2FPR1
SCHEMBL6839419 0.86 F10 (0.78) F10FPR2FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. 2004-08-26 US claimed
EP-1539686-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2005-06-15 EP disclosed
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. 2004-08-26 US disclosed
WO-2004024679-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade TFPI, SERPINC1, F11 F10 13/4885FPR2 1122/4885FPR1 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.